Career Enhancement Program
职业提升计划
基本信息
- 批准号:10478022
- 负责人:
- 金额:$ 8.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-13 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdjuvantBreastBreast Cancer PatientCareer ChoiceClinicalClinical InvestigatorClinical ResearchClinical SciencesContinuity of Patient CareDNA RepairDefectDevelopmentDisciplineDiseaseDisease ManagementDoctor of PhilosophyEnsureEnvironmentFacultyFundingGeneticGenomic InstabilityGoalsGrantImmunotherapyIndividualInstitutionInvestigationKnowledgeLaboratoriesLaboratory ResearchLinkMalignant NeoplasmsMemorial Sloan-Kettering Cancer CenterMentorsMentorshipMetastatic breast cancerModelingOncologyPathway interactionsPatient CarePatientsPatternPhysiciansPopulationPopulation SciencesProcessResearchResearch PersonnelResearch Project GrantsSECTM1 geneScientistSourceSurgeonTrainingTranslational ResearchTranslationsUnited States National Institutes of HealthWorkcareercertificate programclinical applicationclinical investigationcomparativedesignexperiencefaculty mentorindividualized medicineinterestinvestigator trainingmalignant breast neoplasmmemberprogramsrecruittargeted agenttargeted treatmenttranslational cancer researchtranslational scientisttrend
项目摘要
CAREER ENHANCEMENT PROGRAM RESEARCH PLAN
CEP Director: Simon Powell, MD PhD
CEP Co-Director: Jorge Reis-Filho, MD PhD
Abstract:
The SPORE Career Enhancement Program (CEP) aims to prepare physicians and scientists for independent
careers in translational research in breast cancer. Our goal is that investigators supported through this process
will spend their professional lifetimes conducting translational research in breast cancer and become academic
leaders in the field. Memorial Sloan Kettering Cancer Center (MSKCC) is ideally suited for this task, because of
the scientific and clinical environment at our Manhattan campus and affiliated institutions, and our long tradition
of training physicians and scientists of the highest quality. Our institutional environment includes numerous NIH
training grants, including a K12 grant for translational science training, a T32 grant to train PhDs in translational
research in Oncology, a Certificate Program in Clinical Investigation integrated with the Clinical and Translational
Science Program at Weill Cornell, and a well-established junior faculty mentoring program. We plan to use the
SPORE Career Enhancement funds over the next 5 years to enhance the existing formal mentoring programs.
We will encourage more physician trainees to focus on translational research in breast cancer, in particular to
leverage the emerging knowledge of DNA repair defects and specific patterns of genetic instability in breast
cancers to deliver targeted treatments to individual breast cancer patients. We will strive to attract basic,
translational and population scientists who are interested in devoting their careers to making discoveries that
have a realistic potential to clinical applications. The specific aims of the MSKCC Breast SPORE Career
Enhancement Program are to support the mentoring and research of junior faculty for careers in translational
research in breast cancer, using a dual clinical and laboratory/population science mentorship model, and to
recruit and mentor new junior faculty members to work in breast cancer translational research.
职业增强计划研究计划
CEP主任:西蒙·鲍威尔(Simon Powell),医学博士
CEP联合导演:Jorge Reis-Filho,医学博士
抽象的:
孢子职业增强计划(CEP)旨在为医生和科学家准备独立
乳腺癌转化研究的职业。我们的目标是调查人员在此过程中支持
将花费他们的职业生命来进行乳腺癌的转化研究并成为学术
该领域的领导者。纪念斯隆·克特林癌症中心(MSKCC)非常适合此任务,因为
我们曼哈顿校园和附属机构的科学和临床环境以及我们悠久的传统
培训医师和最高质量的科学家。我们的机构环境包括许多NIH
培训补助金,包括用于转化科学培训的K12赠款,T32赠款,用于培训PHD的翻译
肿瘤学研究,与临床和翻译集成的临床研究证书计划
威尔·康奈尔(Weill Cornell)的科学课程,以及一项良好的初级教师指导计划。我们计划使用
在未来5年内,孢子职业增强基金以增强现有的正式指导计划。
我们将鼓励更多的医师学员专注于乳腺癌的转化研究,特别是
利用乳房中DNA修复缺陷和遗传不稳定性的特定模式的新兴知识
癌症为个别乳腺癌患者提供有针对性的治疗。我们将努力吸引基本,
对奉献职业感兴趣的转化和人口科学家
具有临床应用的现实潜力。 MSKCC乳腺孢子职业的具体目的
增强计划是为了支持翻译职业的初级教师的指导和研究
乳腺癌研究,使用双重临床和实验室/人口科学指导模型,并
招募和导师新的初级教师从事乳腺癌转化研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Simon N. Powell其他文献
A local ATR-dependent checkpoint pathway is activated by a site-specific replication fork block in human cells
人类细胞中的位点特异性复制叉阻断激活局部 ATR 依赖性检查点通路
- DOI:
10.1101/2023.03.26.534293 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Sana Ahmed;Manisha Jalan;Helen E. Grimsley;Aman Sharma;Shyam Twayana;Settapong T. Kosiyatrakul;Christopher Thompson;C. Schildkraut;Simon N. Powell - 通讯作者:
Simon N. Powell
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
对寡进行性乳腺癌或非小细胞肺癌患者进行标准护理全身治疗,联合或不联合立体定向全身放射治疗(综合使用放疗来阻断 [CURB] 寡进行性):开放标签、随机、对照、阶段
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
C. Tsai;Jonathan T. Yang;N. Shaverdian;J. Patel;A. Shepherd;J. Eng;David M Guttmann;Randy Yeh;D. Gelblum;A. Namakydoust;I. Preeshagul;S. Modi;Andrew D Seidman;T. Traina;P. Drullinsky;Jessica Flynn;Zhigang Zhang;A. Rimner;Erin F. Gillespie;Daniel R Gomez;Nancy Y. Lee;Michael Berger;M E Robson;J. Reis;N. Riaz;C. Rudin;Simon N. Powell;Jacqueline Bromberg;Linda Chen;Chau Dang;Jeeban P Das;Julianna Eng;J. Girshman;A. Gucalp;C. Hajj;D. Higginson;A. Iqbal;Atif J Khan;Q. LaPlant;Justin M Mann;Kenneth K. Ng;M. Reyngold;R. Sanford;Andrew D Seidman;Ronak Shah;Jacob Y. Shin;S. Sugarman;T. Traina;Abraham J Wu;Amy J Xu;Wanqing Iris Zhi - 通讯作者:
Wanqing Iris Zhi
The predicted effect of HDR dose heterogeneity on local/regional control for post-surgical patients: Location matters
- DOI:
10.1016/j.brachy.2006.03.090 - 发表时间:
2006-04-01 - 期刊:
- 影响因子:
- 作者:
Joseph O. Deasy;Simon N. Powell;Imran Zoberi - 通讯作者:
Imran Zoberi
Ultrasound-mediated mechanical forces selectively kill tumor cells
超声介导的机械力选择性杀死肿瘤细胞
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
A. Tijore;F. Margadant;Mingxi Yao;Anushya Hariharan;C. Chew;Simon N. Powell;G. Bonney;M. Sheetz - 通讯作者:
M. Sheetz
Ataxia telangiectasia: an investigation of the repair defect in the cell line AT5BIVA by plasmid reconstitution.
毛细血管扩张共济失调:通过质粒重建研究细胞系 AT5BIVA 的修复缺陷。
- DOI:
10.1016/0921-8777(93)90053-j - 发表时间:
1993 - 期刊:
- 影响因子:0
- 作者:
Simon N. Powell;Stephen J. Whitaker;John H. Peacock;Trevor J. McMillan - 通讯作者:
Trevor J. McMillan
Simon N. Powell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Simon N. Powell', 18)}}的其他基金
MSK SPORE in Genomic Instability in Breast Cancer
MSK SPORE 在乳腺癌基因组不稳定性中的作用
- 批准号:
10237877 - 财政年份:2020
- 资助金额:
$ 8.66万 - 项目类别:
MSK SPORE in Genomic Instability in Breast Cancer
MSK SPORE 在乳腺癌基因组不稳定性中的作用
- 批准号:
10704063 - 财政年份:2020
- 资助金额:
$ 8.66万 - 项目类别:
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
乳腺癌同源重组缺陷的定义和针对
- 批准号:
10478008 - 财政年份:2020
- 资助金额:
$ 8.66万 - 项目类别:
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
乳腺癌同源重组缺陷的定义和针对
- 批准号:
10237881 - 财政年份:2020
- 资助金额:
$ 8.66万 - 项目类别:
MSK SPORE in Genomic Instability in Breast Cancer
MSK SPORE 在乳腺癌基因组不稳定性中的作用
- 批准号:
10477981 - 财政年份:2020
- 资助金额:
$ 8.66万 - 项目类别:
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
乳腺癌同源重组缺陷的定义和针对
- 批准号:
10704096 - 财政年份:2020
- 资助金额:
$ 8.66万 - 项目类别:
相似国自然基金
基于人工智能构建心脏功能亚段实现胸部肿瘤个体化放疗新策略
- 批准号:12305394
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
- 批准号:82372743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于多源知识融合与多层级跨模态对齐的胸部影像诊断模型
- 批准号:62361027
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于连续黄金角径向采样的胸部磁共振快速成像算法研究
- 批准号:62301352
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胸部CT和超极化129Xe-MRI对COVID-19康复患者肺结构和功能的随访研究
- 批准号:82272109
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Characterizing Entorhinal Cortex Circuit Dysfunction in an APOE Mouse Model of Chemotherapy-Induced Cognitive Impairment
化疗引起认知障碍的 APOE 小鼠模型中内嗅皮层回路功能障碍的特征
- 批准号:
10677984 - 财政年份:2023
- 资助金额:
$ 8.66万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 8.66万 - 项目类别:
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
免疫调节生物材料可增强 T 细胞对三阴性乳腺癌的反应
- 批准号:
10699815 - 财政年份:2023
- 资助金额:
$ 8.66万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 8.66万 - 项目类别:
Information-Theoretic Surprise-Driven Approach to Enhance Decision Making in Healthcare
信息论惊喜驱动方法增强医疗保健决策
- 批准号:
10575550 - 财政年份:2023
- 资助金额:
$ 8.66万 - 项目类别: